Detalhe da pesquisa
1.
Blocking FSH induces thermogenic adipose tissue and reduces body fat.
Nature
; 546(7656): 107-112, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28538730
2.
Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer.
Proc Natl Acad Sci U S A
; 111(50): 17995-8000, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453078
3.
Bisphosphonates inactivate human EGFRs to exert antitumor actions.
Proc Natl Acad Sci U S A
; 111(50): 17989-94, 2014 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453081
4.
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
Clin Ther
; 31(4): 751-61, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19446148
5.
Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.
Curr Osteoporos Rep
; 7(4): 118-26, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19968915
6.
Insulin resistance and bone: a biological partnership.
Acta Diabetol
; 55(4): 305-314, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333578
7.
Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates.
Ann N Y Acad Sci
; 1117: 273-82, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056047
8.
Cellular and molecular consequences of calcineurin A alpha gene deletion.
Ann N Y Acad Sci
; 1116: 216-26, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17872390
9.
A Unified Pathophysiological Construct of Diabetes and its Complications.
Trends Endocrinol Metab
; 28(9): 645-655, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629897
10.
Nonsteroid immune modulators and bone disease.
Ann N Y Acad Sci
; 1068: 284-96, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16831929
11.
Modeling of serum C-telopeptide levels with daily and monthly oral ibandronate in humans.
Ann N Y Acad Sci
; 1068: 560-3, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16831952
12.
Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Clin Ther
; 28(2): 151-73, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16678639
13.
Long-term proton pump inhibitor therapy and risk of hip fracture.
JAMA
; 296(24): 2947-53, 2006 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17190895
14.
The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the ß-Cell-Centric Classification Schema.
Diabetes Care
; 39(2): 179-86, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26798148
15.
The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
Mayo Clin Proc
; 80(3): 379-88, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15757020
16.
A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD+ sensor.
FASEB J
; 16(3): 302-14, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11874980
17.
Disorders associated with acute rapid and severe bone loss.
J Bone Miner Res
; 18(12): 2083-94, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14672343
18.
Ibandronate: a clinical pharmacological and pharmacokinetic update.
J Clin Pharmacol
; 44(9): 951-65, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15317823
19.
Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the ß-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186.
Diabetes Care
; 39(8): e129-30, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27457644
20.
Evaluating the antifracture efficacy of bisphosphonates.
Rev Recent Clin Trials
; 4(2): 122-30, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19463108